IMVT Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $336,900,200.00
Insider Selling (Last 12 Months): $6,819,306.60

Immunovant Insider Trading History Chart

This chart shows the insider buying and selling history at Immunovant by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$365ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M$0$200MTotal Insider BuyingTotal Insider Selling

Immunovant Share Price & Price History

Current Price: $14.68
Price Change: Price Decrease of -0.11 (-0.74%)
As of 04/11/2025 05:00 PM ET

This chart shows the closing price history over time for IMVT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$14.68Closing price on 04/11/25:

SEC Filings (Institutional Ownership Changes) for Immunovant (NASDAQ:IMVT)

47.08% of Immunovant stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMVT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$115kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100M$0$100MTotal InflowsTotal Outflows
Immunovant logo
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Read More on Immunovant

Today's Range

Now: $14.68
Low: $14.30
High: $14.95

50 Day Range

MA: $18.57
Low: $13.31
High: $22.51

52 Week Range

Now: $14.68
Low: $12.72
High: $34.47

Volume

1,862,077 shs

Average Volume

1,190,097 shs

Market Capitalization

$2.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Immunovant?

Immunovant's top insider shareholders include:
  1. Sciences Ltd Roivant (Director)
  2. Peter Salzmann (CEO)
  3. Julia G Butchko (Insider)
  4. Eva Renee Barnett (CFO)
  5. William L Macias (Insider)
  6. Mark S Levine (Insider)
  7. Jay S Stout (CTO)
  8. Michael Geffner (Insider)
  9. Andrew J Fromkin (Director)
Learn More about top insider investors at Immunovant.

Who are the major institutional investors of Immunovant?

Immunovant's top institutional investors include:
  1. Rhumbline Advisers — 0.05%
  2. GAMMA Investing LLC — 0.00%
Learn More about top institutional investors of Immunovant stock.

Which institutional investors are buying Immunovant stock?

Within the previous quarter, IMVT stock was bought by institutional investors including:
  1. GAMMA Investing LLC
  2. Rhumbline Advisers